Literature DB >> 12707055

beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Karin Klingel1, Jens-Jörg Schnorr, Martina Sauter, Gudrun Szalay, Reinhard Kandolf.   

Abstract

To gain insight into the strategies of the immune system to confer resistance against the development of chronic coxsackievirus B3 (CVB3) myocarditis we compared the course of the disease in C57BL/6 mice, beta2-microglobulin knockout (beta2m(-/-)) mice, and perforin-deficient (perforin(-/-)) mice. We found that perforin(-/-) mice as well as immunocompetent C57BL/6 mice reveal a resistant phenotype with complete elimination of the virus from the heart in the course of acute myocarditis. In contrast, myocardial CVB3 infection of beta2m(-/-) mice was characterized by a significantly higher virus load associated with a fulminant acute inflammatory response and, as a consequence of virus persistence, by the development of chronic myocarditis. Interferon-gamma secretion of stimulated spleen cells was found to be significantly delayed in beta2m(-/-) mice compared to perforin(-/-) mice and C57BL/6 control mice during acute myocarditis. In addition, generation of virus-specific IgG and neutralizing antibodies were found to be significantly decreased in beta2m(-/-) mice during acute infection. From these results we conclude that protection against the development of chronic myocarditis strongly depends on the expression of beta2m, influencing the catabolism of IgG as well as the production of protective cytokines, such as interferon-gamma. Moreover, CVB3-induced cardiac injury and prevention of chronic myocarditis was found to be unrelated to perforin-mediated cytotoxicity in our model system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707055      PMCID: PMC1851178          DOI: 10.1016/s0002-9440(10)64305-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

1.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

Authors:  R Watanabe-Fukunaga; C I Brannan; N Itoh; S Yonehara; N G Copeland; N A Jenkins; S Nagata
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

2.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

3.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Authors:  M K Spriggs; B H Koller; T Sato; P J Morrissey; W C Fanslow; O Smithies; R F Voice; M B Widmer; C R Maliszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

5.  Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.

Authors:  H Koide; Y Kitaura; H Deguchi; A Ukimura; K Kawamura; K Hirai
Journal:  Jpn Circ J       Date:  1992-10

6.  The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma.

Authors:  J Ruby; I Ramshaw
Journal:  Lymphokine Cytokine Res       Date:  1991-10

7.  Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis.

Authors:  A H Weller; M Hall; S A Huber
Journal:  Eur Heart J       Date:  1992-01       Impact factor: 29.983

8.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury.

Authors:  L H Chow; K W Beisel; B M McManus
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

9.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 10.  Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review.

Authors:  S A Misbah; G P Spickett; P C Ryba; J M Hockaday; J S Kroll; C Sherwood; J B Kurtz; E R Moxon; H M Chapel
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

View more
  20 in total

1.  Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

Authors:  Gudrun Szalay; Martina Sauter; Joachim Hald; Andreas Weinzierl; Reinhard Kandolf; Karin Klingel
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain.

Authors:  Amanda E Calvert; Kandice L Dixon; Mark J Delorey; Carol D Blair; John T Roehrig
Journal:  Vaccine       Date:  2013-11-17       Impact factor: 3.641

3.  Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.

Authors:  Sandra Jäkel; Ulrike Kuckelkorn; Gudrun Szalay; Michael Plötz; Kathrin Textoris-Taube; Elisa Opitz; Karin Klingel; Stefan Stevanovic; Reinhard Kandolf; Katja Kotsch; Karl Stangl; Peter M Kloetzel; Antje Voigt
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

4.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.

Authors:  Gudrun Szalay; Silke Meiners; Antje Voigt; Jörg Lauber; Christian Spieth; Nora Speer; Martina Sauter; Ulrike Kuckelkorn; Andreas Zell; Karin Klingel; Karl Stangl; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 6.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.

Authors:  Nikolai Petrovsky; Maximilian Larena; Venkatraman Siddharthan; Natalie A Prow; Roy A Hall; Mario Lobigs; John Morrey
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

8.  Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.

Authors:  Andreas Oliver Weinzierl; Gudrun Szalay; Hartwig Wolburg; Martina Sauter; Hans-Georg Rammensee; Reinhard Kandolf; Stefan Stevanović; Karin Klingel
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

Review 9.  The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).

Authors:  Kory J Lavine; Alexander R Pinto; Slava Epelman; Benjamin J Kopecky; Xavier Clemente-Casares; James Godwin; Nadia Rosenthal; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

10.  Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.

Authors:  Irene Müller; Lisa Janson; Martina Sauter; Kathleen Pappritz; Sophie Van Linthout; Carsten Tschöpe; Karin Klingel
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.